The research was conducted as part of a consortium of five institutions called EMPaCT, Enhancing Minority Participation in Clinical Trials.
UAB researchers say new findings show that a herpes simplex virus therapy may be beneficial in treating malignant gliomas.
The UAB School of Medicine will lead in the establishment of a national research consortium focused on the discovery of new and better drug therapies to treat viral infections.
Find out how a cyclotron works, and what makes UAB's new cyclotron unique among U.S. academic medical centers.
UAB has teamed with the Michael J. Fox Foundation to look for genetic biomarkers for Parkinson’s disease.
The UAB Center for Exercise Medicine hosted the first face-to-face meeting of the newly implemented National Exercise Clinical Trials Network, attracting researchers from 49 institutions across the country.
You might know that sex sells, but did you know that the sex of cells is important in biomedical research?
UAB neuroscientists are pursuing discoveries with the potential to reshape understanding of the brain.
A study reveals a potential new drug pathway target for battling Mycobacterium tuberculosis, or Mtb, the pathogen that causes tuberculosis.
Michael Saag, M.D., served as co-chair of a panel of 27 liver and infectious diseases experts to develop Hepatitis C guidance for clinicians that will live online.